3-Phenyl-1H-Indole-5-Sulfonamides: Structure-Based Drug Design of a Promising Class of Carbonic Anhydrase Inhibitors

E-ISSN： 1873-4286|16|29|3317-3326

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.29, 2010-10, pp. : 3317-3326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-Substituted 3-thiophenesulfonamides as carbonic anhydrase inhibitors

By K C. R L. Holmes J. Wijono M. Wheeler L. Garst M.

European Journal of Medicinal Chemistry, Vol. 31, Iss. 3, 1996-01 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite

Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 625-632

Bentham Science Publishers

Access to resources Recommend Favorite

Anticonvulsant Sulfonamides/Sulfamates/Sulfamides with Carbonic Anhydrase Inhibitory Activity: Drug Design and Mechanism of Action

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. : 661-671

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic Anhydrase Activation and the Drug Design

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. : 708-715

Bentham Science Publishers

Access to resources Recommend Favorite